If you have any problems creating your account, please call (800) 994-0301. Our regular business hours are Monday-Thursday, 9 am-4 pm, and Friday, 10 am-4 pm CST. We are closed on weekends and holidays.
New Hope for Chronic Inflammation, Introducing...
Peskin Pharmaceuticals® has developed a patented medical food, EZtrek® — especially for dietary management with distinctive nutritional requirements, helping to compensate for an impaired delta-6 desaturase metabolic pathway, as diagnosed and evaluated by a physician. This patented, botanical-based lipid formulation is not duplicated by normal/typical dietary modification alone.
This impairment directly leads to increased (chronic) inflammation — a root cause of numerous diseases/disorders, as published in medical journals.
Once this metabolic impairment is (at least partially) compensated for, patient results are often highly significant and remarkable. Representative patient results can be seen in the COPD video and Pain Reduction video.
An Important Update From Physicians Utilizing EZtrek®
Physicians report that patients taking Eztrek®, a 1/2 dose in the morning and 1/2 dose at bedtime, are getting improved results. Also, increasing the daily dosage to one teaspoon in the morning, then one teaspoon at bedtime (two teaspoons/day) is optimal for more serious inflammation-based issues.
Physicians report that patients taking Eztrek®, a 1/2 dose in the morning and 1/2 dose at bedtime, are getting improved results. Also, increasing the daily dosage to one teaspoon in the morning, then one teaspoon at bedtime (two teaspoons/day) is optimal for more serious inflammation-based issues.





